Branded Generics Market: Growth Drivers, Restraints and Opportunities Branded Generics Market | Page 2

Summary: The branded generics market estimated to be valued US$ 224.0 Bn in 2017 and poised to grow at CAGR 7.7 %. Market for branded generics projected to reach US$ 350.0 Bn by 2023. Market key players: Abbott Laboratories, Apotex Inc., AstraZeneca, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, Mylan N.V., Pfizer Inc., Novartis AG, Sanofi, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd, Valeant Pharmaceuticals International, Inc. Ask for Discount: https://www.ingeniousreports.com/Global-Branded-Generics-Market-By-Disease-Indication- Cardiovascular-Diseases-Diabetes-Cancer-Neurological-Disorders-Gastrointestinal-Diseases-Dermatology-Diseases- and-Others-By-Route-of-Administration-Oral-Parenteral-Topical-and-Others-By-Distribution-Cha By Diseases Indication - Cardiovascular Diseases, Diabetes, Cancer, Neurological Disorders, Gastrointestinal Diseases, Dermatology Diseases, Others By Route of Administration - Oral, Parenteral, Topical, Others By Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies Key Findings of the Report: • • • • Branded Generics market expanding at 7.7% CAGR over 2017 to 2023 to reach market value of US$ 350.0 Bn by 2023 owing increase in prevalence of chronic and life style disease in emerging markets Based on diseases Indication, cardiovascular diseases sub-segment projected to garner larger market revenue share in over forecast period owing to rising co-morbidities like diabetes and cardiovascular diseases Hospital and retail pharmacies are prime distribution channels for branded generics across the regions owing to accessibility and availability drugs Players focusing on increasing geographic foot-prints to garner growing market opportunities in developing countries Key Features of the Report: • • • • • • The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023) The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market The report tracks recent innovations, key developments and startup’s details that are actively working in the market The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market Table of Content: • • • • • • • Global Branded Generics in Market Dynamics Unique Features of the Report Global Branded Generics Market Analysis, By Diseases Indication, 2012 - 2016 and Forecast, 2017 - 2023 Global Branded Generics Market Analysis, By Route of Administration, 2012 - 2016 and Forecast, 2017 - 2023 Branded Generics in Market Forecast, By Distribution Channel, 2012 - 2016 and Forecast, 2017 - 2023 Global Branded Generics Market Analysis, By Region, 2012 - 2016 and Forecast, 2017 - 2023 Competition Landscape 01